Literature DB >> 29478868

Management of Heart Failure in Advancing CKD: Core Curriculum 2018.

Andrew A House1.   

Abstract

Heart failure and chronic kidney disease have increasing incidence and prevalence owing in part to the aging population and increasing rates of hypertension, diabetes, and other cardiovascular and kidney disease risk factors. The presence of one condition also has a strong influence on the other, leading to greater risks for hospitalization, morbidity, and death, as well as very high health care costs. Despite the frequent coexistence of heart failure and chronic kidney disease, many of the pivotal randomized trials that guide the management of heart failure have excluded patients with more advanced stages of chronic kidney disease. In this Core Curriculum article, management of a challenging, yet not unusual, case of heart failure with reduced ejection fraction in a patient with stage 4 chronic kidney disease provides an opportunity to review the relevant literature and highlight gaps in our knowledge.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure (HF); cardiorenal syndrome (CRS); chronic kidney disease (CKD); chronic renal failure; congestive heart failure (CHF); heart failure with reduced ejection fraction; kidney failure; review; worsening kidney function

Mesh:

Year:  2018        PMID: 29478868     DOI: 10.1053/j.ajkd.2017.12.006

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

Review 1.  [Drug treatment of heart failure in chronic kidney disease].

Authors:  Nikolaus Marx
Journal:  Internist (Berl)       Date:  2020-04       Impact factor: 0.743

2.  The Role of Vitamin D3 as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure.

Authors:  Kirsten Thiele; Anne Cornelissen; Roberta Florescu; Kinan Kneizeh; Vincent Matthias Brandenburg; Klaus Witte; Nikolaus Marx; Alexander Schuh; Robert Stöhr
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

3.  Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction.

Authors:  Aaron J Velasquez-Mao; Mark A Velasquez; Zhengxiong Hui; Denise Armas-Ayon; Jingshen Wang; Moriel H Vandsburger
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.

Authors:  Šárka Vacková; Libor Kopkan; Soňa Kikerlová; Zuzana Husková; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Bruce D Hammock; John D Imig; Miloš Táborský; Vojtěch Melenovský; Luděk Červenka
Journal:  Front Pharmacol       Date:  2019-01-23       Impact factor: 5.810

5.  Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis.

Authors:  Ning Li; Guowei Zhou; Yawei Zheng; Dan Lv; Xiangjun Zhu; Ping Wei; Min Zheng; Shijia Liu; Enchao Zhou; Wei Sun; Lu Zhang
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

6.  Correlation between serum levels of microRNA-21 and inflammatory factors in patients with chronic heart failure.

Authors:  Weiwei Li; Yanan Li; Feng Jiang; Huan Liu
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

7.  Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer.

Authors:  Jonathan Slawik; Juliane Dederer; Ingrid Kindermann; Michael Böhm
Journal:  ESC Heart Fail       Date:  2020-06-17

8.  Successful Treatment of Severe Heart Failure in Advanced Diabetic Kidney Disease Using Angiotensin-neprilysin Inhibitors (Sacubitril/Valsartan) - Report of Two Cases with Review of Options in Literature.

Authors:  Ratan Jha; Kiran K Mukku; Ambati K Rakesh; Sumeet Sinha
Journal:  Indian J Nephrol       Date:  2021-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.